Fakultni nemocnice Hradec Kralove

Nový Hradec Králové 50005

1 studies enrolling now · 2 studies all time

What they study most

Advanced or Metastatic NRAS-mutant Melanoma, Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Non Hodgkin Lymphoma

Studies at this site

• Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL — Recruiting now
• A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) — Running, not enrolling